Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 2, 2026
Sale
Shares
18,442
Price
$2.20
Total Value
$40.57K
Shares Held After
1,100,008
% of Holdings
1.6%
Feb 2, 2026
Sale
Shares
7,039
Price
$18.02
Total Value
$126.84K
Shares Held After
358,234
% of Holdings
1.9%
Feb 2, 2026
Sale
Shares
14,043
Price
$32.87
Total Value
$461.59K
Shares Held After
657,540
% of Holdings
2.1%
Feb 2, 2026
Sale
Shares
957
Price
$31.82
Total Value
$30.45K
Shares Held After
671,583
% of Holdings
0.1%
Feb 2, 2026
Sale
Shares
100
Price
$234.00
Total Value
$23.40K
Shares Held After
127,881
% of Holdings
0.1%
Feb 2, 2026
Sale
Shares
7,445
Price
$233.31
Total Value
$1.74M
Shares Held After
127,981
% of Holdings
5.5%
Feb 2, 2026
Sale
Shares
9,197
Price
$232.41
Total Value
$2.14M
Shares Held After
135,426
% of Holdings
6.4%
Feb 2, 2026
Sale
Shares
20,079
Price
$230.95
Total Value
$4.64M
Shares Held After
144,623
% of Holdings
12.2%
Feb 2, 2026
Sale
Shares
41,847
Price
$230.03
Total Value
$9.63M
Shares Held After
164,702
% of Holdings
20.3%
Feb 2, 2026
Sale
Shares
6,631
Price
$229.08
Total Value
$1.52M
Shares Held After
206,549
% of Holdings
3.1%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
16
Price
$234.00
Total Value
$3.74K
Shares Held After
139,486
% of Holdings
0.0%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
600
Price
$233.24
Total Value
$139.94K
Shares Held After
139,502
% of Holdings
0.4%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
850
Price
$232.33
Total Value
$197.48K
Shares Held After
140,102
% of Holdings
0.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
576
Price
$230.84
Total Value
$132.96K
Shares Held After
140,952
% of Holdings
0.4%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
878
Price
$229.96
Total Value
$201.90K
Shares Held After
141,528
% of Holdings
0.6%

Natera, Inc. (NTRA)

Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Feb 2, 2026
Sale
Shares
80
Price
$228.50
Total Value
$18.28K
Shares Held After
142,406
% of Holdings
0.1%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
231,138
% of Holdings
0.0%
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,238
% of Holdings
0.0%
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
231,338
% of Holdings
0.0%
Shares
90
Price
$3.05
Total Value
$274.50
Shares Held After
231,348
% of Holdings
0.0%
Shares
100
Price
$3.07
Total Value
$307.00
Shares Held After
231,438
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,538
% of Holdings
0.0%
Shares
100
Price
$3.06
Total Value
$306.00
Shares Held After
231,588
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
231,688
% of Holdings
0.0%
Shares
82
Price
$3.05
Total Value
$250.10
Shares Held After
231,738
% of Holdings
0.0%
Shares
98
Price
$3.05
Total Value
$298.90
Shares Held After
231,820
% of Holdings
0.0%
Shares
417
Price
$3.05
Total Value
$1.27K
Shares Held After
231,918
% of Holdings
0.2%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,335
% of Holdings
0.0%
Shares
2
Price
$3.05
Total Value
$6.10
Shares Held After
232,385
% of Holdings
0.0%
Shares
183
Price
$3.05
Total Value
$558.15
Shares Held After
232,387
% of Holdings
0.1%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,570
% of Holdings
0.0%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,670
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,770
% of Holdings
0.0%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
232,820
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,920
% of Holdings
0.0%
Shares
18
Price
$3.05
Total Value
$54.90
Shares Held After
232,970
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
232,988
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,038
% of Holdings
0.0%
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,088
% of Holdings
0.0%
Shares
500
Price
$3.05
Total Value
$1.52K
Shares Held After
233,138
% of Holdings
0.2%
Shares
200
Price
$3.06
Total Value
$612.00
Shares Held After
233,638
% of Holdings
0.1%
Shares
100
Price
$3.04
Total Value
$304.00
Shares Held After
233,838
% of Holdings
0.0%
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,938
% of Holdings
0.0%
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,942
% of Holdings
0.0%
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
233,946
% of Holdings
0.0%
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
233,956
% of Holdings
0.0%
Feb 2, 2026
Sale
Shares
2,540
Price
$2.55
Total Value
$6.48K
Shares Held After
187,286
% of Holdings
1.3%

OCULAR THERAPEUTIX, INC (OCUL)

Notman Donald — Chief Operating Officer
Feb 2, 2026
Sale
Shares
5,455
Price
$9.14
Total Value
$49.86K
Shares Held After
383,837
% of Holdings
1.4%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Feb 2, 2026
Sale
Shares
4,714
Price
$25.63
Total Value
$120.82K
Shares Held After
110,003
% of Holdings
4.1%

Arcutis Biotherapeutics, Inc. (ARQT)

Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Feb 2, 2026
Sale
Shares
19,379
Price
$25.24
Total Value
$489.13K
Shares Held After
114,717
% of Holdings
14.5%
Version: v26.3.33